Harmony Biosciences Holdings Inc (NAS:HRMY)
$ 34.2 -0.52 (-1.5%) Market Cap: 1.95 Bil Enterprise Value: 1.75 Bil PE Ratio: 16.21 PB Ratio: 3.27 GF Score: 65/100

Q1 2024 Harmony Biosciences Holdings Inc Earnings Call Transcript

Apr 30, 2024 / 12:30PM GMT
Release Date Price: $30.91 (+5.68%)
Operator

Good morning. My name is Madison, and I will be your conference operator today. At this time, I would like to welcome everyone to Harmony Biosciences' first quarter 2024 financial results conference call. (Operator Instructions) Please be advised that today's conference may be recorded. (Operator Instructions) I will now turn the call over to Lewis Head of Investor Relations.

Luis Sanay
Harmony Biosciences Holdings Inc - Head of Investor Relation

Thank you, operator. Good morning, everyone, and thank you for joining us today as we review Harmony Biosciences' First Quarter 2024 financial results and provide a business update.

Before we start, I encourage everyone to go to the Investors section of our website to find the materials that accompany our discussion today, including a reconciliation of our GAAP to non-GAAP financial measures at this stage of our life cycle, we believe non-GAAP financial results better represent the underlying business performance.

Our speakers on today's call are Dr. Jeffrey Dayno, President and CEO; Jeffrey Dierks,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot